Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by silvarlineon Mar 12, 2013 10:55pm

204 Views

Post# 21120280

RE: Virusmax

The reply of the patent proprietor to the notice of opposition is very detailed and provides strong support for all claims in the patent (EP1636352). So we will wait and see …

If the EPO favors MBX, then …. “Novartis , we have problem”.

In conversation with Mr. Pantalony at the AGM he mentioned that we might have some "indication" in April.

Rovam ... did you find what you were looking i.e. inbox.

Not the same lawyers as with Lumisort

Walker, Ross Thomson

Forrester & Boehmert

SkyGarden

Erika-Mann-Strasse 11

80636 Munchen

DE

Bullboard Posts

The top 10 Canadian medical stocks